Logos Global Management LP Aclaris Therapeutics, Inc. Transaction History

Logos Global Management LP

  • $1.07 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$7.89 - $10.64 $4.14 Million - $5.59 Million
525,000 New
525,000 $5.44 Million
Q3 2021

Nov 15, 2021
SELL
$13.38 - $18.8 $9.03 Million - $12.7 Million
-675,000 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$17.08 - $29.6 $11.5 Million - $20 Million
675,000 New
675,000 $11.9 Million

Others Institutions Holding ACRS

# of Institutions
97
Shares Held
52.4M
Call Options Held
32.4K
Put Options Held
3.3K
View Full List

About Aclaris Therapeutics, Inc.

ACRS Quotes by TradingView
  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $139M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email